Antiflammins inhibit synthesis of platelet-activating factor and intradermal inflammatory reactions.
Camussi
G
G
Dipartimento di Biochimica e Biofisica, 1a Facoltà di Medicina, Università di Napoli.
Tetta
C
C
Baglioni
C
C
D000595:Amino Acid Sequence; D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal; D006801:Humans; D066298:In Vitro Techniques; D008264:Macrophages / Q000187:drug effects / Q000378:metabolism; D008969:Molecular Sequence Data; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism; D009842:Oligopeptides / Q000494:pharmacology*; D010446:Peptide Fragments / Q000494:pharmacology*; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D010972:Platelet Activating Factor / Q000096:biosynthesis*; D051381:Rats; D014598:Uteroglobin / Q000494:pharmacology*
D000894:Anti-Inflammatory Agents, Non-Steroidal; D009842:Oligopeptides; D010446:Peptide Fragments; D010972:Platelet Activating Factor; C064645:antiflammin P1; C064647:antiflammin P2; D014598:Uteroglobin; D010741:Phospholipases A